Bill > H0528

This bill establishes provisions for directed blood product transfusions, defining "blood product" to include whole blood, plasma, derivatives, platelets, and clotting agents. It generally prohibits healthcare providers or facilities from preventing a patient from using their own blood or blood from a directed donor, provided it's collected by a federally compliant blood establishment, for their healthcare needs. However, this right is not absolute and does not apply if the donation or transfusion would be harmful, if there isn't enough time to arrange for the directed donation before a procedure, or if the procedure is an emergency medical service. Healthcare providers and facilities are granted immunity from liability for issues arising from the use of such directed blood products, unless their gross negligence is a contributing factor. The bill also clarifies that it does not conflict with federal laws regarding blood products and declares an emergency, making the act effective on July 1, 2026.

Health and Social Services

Health and Welfare Committee (House)

https://legislature.idaho.gov/sessioninfo/2026/legislation/H0528/